5-HT1B receptor regulation of serotonin (5-HT) release by endogenous 5-HT in the substantia nigra

Neuroscience

Volumn 165, Issue 1, 2010, Pages 212-220

  Threlfell, S ^a   Greenfield, S A ^a   Cragg, S J ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Department of Physiology Anatomy and Genetics ^*  (United Kingdom)

Author keywords

autoinhibition; autoreceptor; basal ganglia; fast scan cyclic voltammetry; substantia nigra pars reticulata; synaptic transmission

Indexed keywords

2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; CARBON FIBER; ISAMOLTANE; PICROTOXIN; SACLOFEN; SEROTONIN; SEROTONIN 1B RECEPTOR; THIOPERAMIDE;

ANIMAL TISSUE; ARTICLE; AUTOREGULATION; BRAIN SLICE; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; GABAERGIC SYSTEM; INNERVATION; MALE; MICROELECTRODE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SEROTONIN RELEASE; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION;

ANIMALS; ELECTRIC STIMULATION; GAMMA-AMINOBUTYRIC ACID; HISTAMINE; MALE; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN; SUBSTANTIA NIGRA;

EID: 70449635084     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.10.005     Document Type: Article

References (50)

1. Adell A., Celada P., and Artigas F. The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain. J Neurochem 79 (2001) 172-182
2. Adham N., Romanienko P., Hartig P., Weinshank R.L., and Branchek T. The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor. Mol Pharmacol 41 (1992) 1-7
3. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
4. Bauer K., Dietersdorfer F., and Kaik G. Assessment of beta-adrenergic receptor blockade after isamoltane, a 5-HT1-receptor active compound, in healthy volunteers. Clin Pharmacol Ther 53 (1993) 675-683
5. Benoit-Marand M., Borrelli E., and Gonon F. Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J Neurosci 21 (2001) 9134-9141
6. Boschert U., Amara D.A., Segu L., and Hen R. The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience 58 (1994) 167-182
7. Bruinvels A.T., Landwehrmeyer B., Gustafson E.L., Durkin M.M., Mengod G., Branchek T.A., Hoyer D., and Palacios J.M. Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33 (1994) 367-386
8. Bruinvels A.T., Palacios J.M., and Hoyer D. Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain. Naunyn Schmiedebergs Arch Pharmacol 347 (1993) 569-582
9. Corvaja N., Doucet G., and Bolam J.P. Ultrastructure and synaptic targets of the raphe-nigral projection in the rat. Neuroscience 55 (1993) 417-427
10. Cragg S.J. Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum. J Neurosci 23 (2003) 4378-4385
11. Cragg S.J., and Greenfield S.A. Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J Neurosci 17 (1997) 5738-5746
12. Cragg S.J., Hawkey C.R., and Greenfield S.A. Comparison of serotonin and dopamine release in substantia nigra and ventral tegmental area: region and species differences. J Neurochem 69 (1997) 2378-2386
13. Davidson C., and Stamford J.A. Evidence that 5-hydroxytryptamine release in rat dorsal raphe nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors. Br J Pharmacol 114 (1995) 1107-1109
14. Doucet E., Pohl M., Fattaccini C.M., Adrien J., Mestikawy S.E., and Hamon M. In situ hybridization evidence for the synthesis of 5-HT1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain. Synapse 19 (1995) 18-28
15. Exley R., Clements M.A., Hartung H., McIntosh J.M., and Cragg S.J. Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology 33 (2008) 2158-2166
16. Gaster L.M., Blaney F.E., Davies S., Duckworth D.M., Ham P., Jenkins S., Jennings A.J., Joiner G.F., King F.D., Mulholland K.R., Wyman P.A., Hagan J.J., Hatcher J., Jones B.J., Middlemiss D.N., Price G.W., Riley G., Roberts C., Routledge C., Selkirk J., and Slade P.D. The selective 5-HT1B receptor inverse agonist 1′-methyl-5-[[2′-methyl-4′-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro-spiro[furo[2,3-f]indole-3,4′-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. J Med Chem 41 (1998) 1218-1235
17. Hajos M., Allers K.A., Jennings K., Sharp T., Charette G., Sik A., and Kocsis B. Neurochemical identification of stereotypic burst-firing neurons in the rat dorsal raphe nucleus using juxtacellular labelling methods. Eur J Neurosci 25 (2007) 119-126
18. Hajos M., Gartside S.E., Villa A.E., and Sharp T. Evidence for a repetitive (burst) firing pattern in a sub-population of 5-hydroxytryptamine neurons in the dorsal and median raphe nuclei of the rat. Neuroscience 69 (1995) 189-197
19. Hopwood S.E., and Stamford J.A. Multiple 5-HT(1) autoreceptor subtypes govern serotonin release in dorsal and median raphe nuclei. Neuropharmacology 40 (2001) 508-519
20. Iravani M.M., and Kruk Z.L. Real-time measurement of stimulated 5-hydroxytryptamine release in rat substantia nigra pars reticulata brain slices. Synapse 25 (1997) 93-102
21. Jackson M.J., Al-Barghouthy G., Pearce R.K., Smith L., Hagan J.J., and Jenner P. Effect of 5-HT1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets. Pharmacol Biochem Behav 79 (2004) 391-400
22. John C.E., Budygin E.A., Mateo Y., and Jones S.R. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse. J Neurochem 96 (2006) 267-282
23. Johnson S.W., Mercuri N.B., and North R.A. 5-Hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons. J Neurosci 12 (1992) 2000-2006
24. 2+ ions during measurements of catecholamine release in slices of rat amygdala with fast-scan cyclic voltammetry. J Neurosci Methods 52 (1994) 1-10
25. Kennedy R.T., Jones S.R., and Wightman R.M. Dynamic observation of dopamine autoreceptor effects in rat striatal slices. J Neurochem 59 (1992) 449-455
26. Knobelman D.A., Kung H.F., and Lucki I. Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors. J Pharmacol Exp Ther 292 (2000) 1111-1117
27. Li Y.W., and Bayliss D.A. Presynaptic inhibition by 5-HT1B receptors of glutamatergic synaptic inputs onto serotonergic caudal raphe neurones in rat. J Physiol 510 Pt 1 (1998) 121-134
28. Maura G., and Raiteri M. Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release. Eur J Pharmacol 129 (1986) 333-337
29. O'Connor J.J., and Kruk Z.L. Frequency dependence of 5-HT autoreceptor function in rat dorsal raphe and suprachiasmatic nuclei studied using fast cyclic voltammetry. Brain Res 568 (1991) 123-130
30. Palij P., and Stamford J.A. Real-time monitoring of endogenous noradrenaline release in rat brain slices using fast cyclic voltammetry. 2. Operational characteristics of the alpha 2 autoreceptor in the bed nucleus of stria terminalis, pars ventralis. Brain Res 607 (1993) 134-140
31. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1982), Academic Press, San Diego
32. Pazos A., and Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346 (1985) 205-230
33. Phillips P.E., Hancock P.J., and Stamford J.A. Time window of autoreceptor-mediated inhibition of limbic and striatal dopamine release. Synapse 44 (2002) 15-22
34. Riad M., Garcia S., Watkins K.C., Jodoin N., Doucet E., Langlois X., El Mestikawy S., Hamon M., and Descarries L. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol 417 (2000) 181-194
35. Roberts C., Price G.W., and Jones B.J. The role of 5-HT(1B/1D) receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig. Eur J Pharmacol 326 (1997) 23-30
36. Sarhan H., Cloez-Tayarani I., Massot O., Fillion M.P., and Fillion G. 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes. Naunyn Schmiedebergs Arch Pharmacol 359 (1999) 40-47
37. Sari Y., Miquel M.C., Brisorgueil M.J., Ruiz G., Doucet E., Hamon M., and Verge D. Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 88 (1999) 899-915
38. Sari Y., Lefevre K., Bancila M., Quignon M., Miquel M.C., Langlois X., Hamon M., and Verge D. Light and electron microscopic immunocytochemical visualization of 5-HT1B receptors in the rat brain. Brain Res 760 (1997) 281-286
39. Schmitz Y., Schmauss C., and Sulzer D. Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J Neurosci 22 (2002) 8002-8009
40. Selkirk J.V., Scott C., Ho M., Burton M.J., Watson J., Gaster L.M., Collin L., Jones B.J., Middlemiss D.N., and Price G.W. SB-224289-a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity. Br J Pharmacol 125 (1998) 202-208
41. Sharp T., Bramwell S.R., and Grahame-Smith D.G. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 96 (1989) 283-290
42. Stamford J.A., Davidson C., McLaughlin D.P., and Hopwood S.E. Control of dorsal raphe 5-HT function by multiple 5-HT(1) autoreceptors: parallel purposes or pointless plurality?. Trends Neurosci 23 (2000) 459-465
43. Svenningsson P., Chergui K., Rachleff I., Flajolet M., Zhang X., El Yacoubi M., Vaugeois J.M., Nomikos G.G., and Greengard P. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311 (2006) 77-80
44. Thomson A.M. Molecular frequency filters at central synapses. Prog Neurobiol 62 (2000) 159-196
45. Threlfell S., Cragg S.J., Kallo I., Turi G.F., Coen C.W., and Greenfield S.A. Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata. J Neurosci 24 (2004) 8704-8710
46. Threlfell S., Exley R., Cragg S.J., and Greenfield S.A. Constitutive histamine H2 receptor activity regulates serotonin release in the substantia nigra. J Neurochem 107 (2008) 745-755
47. van der Kooy D., and Hattori T. Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat. Brain Res 186 (1980) 1-7
48. Verge D., Daval G., Marcinkiewicz M., Patey A., El Mestikawy S., Gozlan H., and Hamon M. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci 6 (1986) 3474-3482
49. Vilardaga J.P., Bunemann M., Krasel C., Castro M., and Lohse M.J. Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat Biotechnol 21 (2003) 807-812
50. Wirtshafter D., Stratford T.R., and Asin K.E. Evidence that serotonergic projections to the substantia nigra in the rat arise in the dorsal, but not the median, raphe nucleus. Neurosci Lett 77 (1987) 261-266